Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare transitional cell carcinoma that arises from the fallopian tube.
Biomarker and diagnostic research for fallopian tube transitional cell carcinoma has been reported in the published literature.
9 clinical trials registered. Interventions under study include procedural interventions, drug therapy, other interventions, and biologic therapy. Pipeline includes 4 PHASE3, 3 PHASE2, 2 PHASE1. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT02834013](https://clinicaltrials.gov/study/NCT02834013) |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:12 AM UTC
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors |
PHASE2 |
National Cancer Institute (NCI) |
UNKNOWN |
[NCT02502266](https://clinicaltrials.gov/study/NCT02502266) | Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer | PHASE2 | National Cancer Institute (NCI) | UNKNOWN |
[NCT02068794](https://clinicaltrials.gov/study/NCT02068794) | MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer | PHASE1 | Mayo Clinic | UNKNOWN |
[NCT04739800](https://clinicaltrials.gov/study/NCT04739800) | Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents | PHASE2 | National Cancer Institute (NCI) | UNKNOWN |
[NCT01167712](https://clinicaltrials.gov/study/NCT01167712) | Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | PHASE3 | National Cancer Institute (NCI) | UNKNOWN |
92 publications have been identified in PubMed for fallopian tube transitional cell carcinoma. Research spans Basic Science / Preclinical (58%), Case Report / Case Series (10%), and Review / Meta-Analysis (9%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 53 | 58% |
Patient case studies | 9 | 10% |
Research summaries | 8 | 9% |
Testing and diagnosis research | 7 | 8% |
Clinical study results | 7 | 8% |
New treatment approaches | 6 | 7% |
Disease patterns and progression | 2 | 2% |
Nelson OL (2026). [PMID: 41825096](https://pubmed.ncbi.nlm.nih.gov/41825096/). *Gynecologic oncology*. [Basic Science / Preclinical]
Soong TR (2026). [PMID: 41923499](https://pubmed.ncbi.nlm.nih.gov/41923499/). *Cancer research*. [Review / Meta-Analysis]
An J (2026). [PMID: 40571640](https://pubmed.ncbi.nlm.nih.gov/40571640/). *The Tohoku journal of experimental medicine*. [Case Report / Case Series]
Roy O (2026). [PMID: 41677632](https://pubmed.ncbi.nlm.nih.gov/41677632/). *Cells*. [Diagnostic / Biomarker]
Canário R (2026). [PMID: 40320493](https://pubmed.ncbi.nlm.nih.gov/40320493/). *Virchows Archiv : an international journal of pathology*. [Basic Science / Preclinical]
Webb JD (2026). [PMID: 41786876](https://pubmed.ncbi.nlm.nih.gov/41786876/). *Oncogene*. [Basic Science / Preclinical]
Ma Y (2026). [PMID: 41388793](https://pubmed.ncbi.nlm.nih.gov/41388793/). *Diagnostic cytopathology*. [Basic Science / Preclinical]
Kader T (2026). [PMID: 41999663](https://pubmed.ncbi.nlm.nih.gov/41999663/). *Cancer Discov*. [Basic Science / Preclinical]
Landon BV (2026). [PMID: 41652014](https://pubmed.ncbi.nlm.nih.gov/41652014/). *Communications medicine*. [Case Report / Case Series]
Khine AA (2026). [PMID: 41539067](https://pubmed.ncbi.nlm.nih.gov/41539067/). *Tissue & cell*. [Case Report / Case Series]